medicare drug price negotiations

Tomorrow marks the two-year anniversary of the misnamed Inflation Reduction Act (IRA). The law has had little impact on inflation but has had a big impact on the pharmaceutical industry; just not in the way that the Biden-Harris Administration would have you believe. According to recent reports, the IRA’s drug price-fixing scheme is leading to […]

Price controls are failing. We need a better way.

Neither of these measures will reduce inflation – in fact, the added subsidies will do the opposite by incentivizing insurers to continue raising rates.

Government price controls mean fewer new breakthrough cures for patients and their families, less research on new cancer treatments, and hundreds of millions of lives cut short.

Government price controls mean a future with as many as 342 fewer new cures for cancer, Alzheimer’s, and other leading diseases

The new campaign comes as Congress prepares to revive drug price control provision included in last year’s failed “Build Back Better” plan.

Putting Washington in charge of drug prices would stifle innovation and lead to fewer life-saving cures.

“America – we lead the world in access to new drugs and cures for cancer, AIDS and COVID. But some in Washington would put that at risk with a 95 percent drug tax and a loss of control over the medicines you need.”